Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
about
Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancerPharmaceutical-grade albumin: impaired drug-binding capacity in vitroIsolation and characterization of serum albumin from Camelus dromedarius.Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site.Analysis of chiral non-steroidal anti-inflammatory drugs flurbiprofen, ketoprofen and etodolac binding with HSA.
P2860
Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
@ast
Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
@en
type
label
Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
@ast
Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
@en
prefLabel
Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
@ast
Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
@en
P1476
Reversible ligand binding to human serum albumin. Theoretical and clinical aspects.
@en
P2093
P304
P577
1999-11-01T00:00:00Z